Pfizer Czech Republic made a net profit of CZK 103 mil in 2017, up 39.7% compared to the previous year. Historically, between 2002 and 2017, the company's net profit reached a high of CZK 272 mil in 2008 and a low of CZK -263 mil in 2002.
The result implies a return on equity of 7.86% and a return on invested capital of 6.11% in 2017. That is compared to an average of 7.68% and 10.7% over the last five years.
The company has been operating with average EBITDA margin of 3.65% in the last 5 years and an average net margin of 2.58%.
Since 2012, the firm's net profit increased by 113% or an average of 16.4% a year.
You can see all the company’s data at Pfizer Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
